Magnetic resonance imaging assessing the correlation of components and prognosis in myxoid liposarcoma

磁共振成像评估黏液样脂肪肉瘤成分与预后的相关性

阅读:1

Abstract

BackgroundMyxoid liposarcoma (MLS) is a subtype of liposarcoma characterized by its myxoid stroma and adipocyte differentiation. MLS is prone to recurrence and metastasis. Magnetic resonance imaging (MRI) plays a crucial role in evaluating tumor characteristics, enabling accurate diagnosis, and predicting patient prognosis.PurposeTo analyze the components of MLS by MRI features and assess their correlation with prognosis.Material and MethodsA total of 20 patients with MLS who underwent MRI were retrospectively included. Tumor components were analyzed by MRI features, and their prognostic correlation was assessed. Patients were divided into good and poor prognosis groups based on postoperative follow-up.ResultsThe proportions of non-fatty/non-myxoid components in the good and poor prognosis groups were 15.00% (range = 10.00%-20.00%) and 70.00% (range = 52.50%-77.50%), respectively (P < 0.001). The proportion of myxoid composition also differed significantly between the two groups (75.00%, [range = 65.00%-85.00%] vs. 25.00% [range = 17.50%-42.50%]; P < 0.001). The good prognosis group had a greater mean apparent diffusion coefficient (ADC) value (1.66 ± 0.23 × 10(-3) mm(2)/s) and a lower mean ADC low signal ratio (5.00% [range = 0%-10.00%]) in the non-fatty/non-myxoid areas than the poor group (1.21 ± 0.41 × 10(-3) mm(2)/s; 20.00% [range = 11.00%-39.00%]; P = 0.006 and P = 0.001). The differences in the percentages of patients with a component ratio <25% and >50% in both the non-fatty/non-myxoid and myxoid groups were significant (P < 0.001 and P = 0.005).ConclusionImaging features were closely associated with the histological components of MLS. The use of MRI features for assessing MLS components has important implications for prognostic prediction.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。